Skip to content

Physical therapy for non-specific chronic low back pain derived from occupational risk

Pre-clinical and post-clinical evaluation of physical therapy rehabilitation on non-specific chronic low back pain derived from occupational risk: a pilot study with an intervention of 4-week follow-up

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN79081718
Enrollment
457
Registered
2021-03-25
Start date
2020-10-08
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-specific chronic low back pain derived from occupational risk Musculoskeletal Diseases Low back pain

Interventions

Participants are recruited by an internal call for low back pain during the last 12 months. All participants were diagnosed with non-specific chronic low back pain derived from occupational risk. The

Sponsors

National Autonomous University of Mexico
Lead Sponsor
University of the Valley of Mexico
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Worker with localized chronic low back pain (= 6 months) presenting mild, mild-moderate and/or moderate pain, according to the VAS scale 2. Pain associated with an occupational risk 3. Constant and collaborative patient 4. Not receiving pharmacological treatment 5. Without aggravating family history 6. Aged 20 to 55 years 7. Actively working in the company

Exclusion criteria

Exclusion criteria: 1. Workers who are receiving pharmacological treatment prior to or during the study 2. Non-cooperative worker 3. Neoplastic process 4. Neurological disorders 5. Pregnancy 6. Previous or current trauma 7. Obesity

Design outcomes

Primary

MeasureTime frame
Pain measured using a visual analogue scale (VAS) at baseline (pre-treatment) and after 4 weeks (post-treatment)

Secondary

MeasureTime frame
1. Kinesophobia measured using the Tampa scale of Kinesophobia at baseline (pre-treatment) and after 4 weeks (post-treatment) 2. Disability measured using the Oswestry Questionnaire at baseline (pre-treatment) and after 4 weeks (post-treatment) 3. Sleep quality measured using the Pittsburgh Questionnaire at baseline (pre-treatment) and after 4 weeks (post-treatment) 4. Quality of life measured using the short form 36 questionnaire (SF-36) at baseline (pre-treatment) and after 4 weeks (post-treatment)

Countries

Mexico

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026